Danaher Co. (NYSE:DHR) Shares Purchased by Baader Bank Aktiengesellschaft

Baader Bank Aktiengesellschaft increased its stake in shares of Danaher Co. (NYSE:DHR) by 1.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 44,723 shares of the conglomerate’s stock after purchasing an additional 470 shares during the period. Danaher makes up approximately 0.7% of Baader Bank Aktiengesellschaft’s investment portfolio, making the stock its 20th largest position. Baader Bank Aktiengesellschaft’s holdings in Danaher were worth $10,266,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Defender Capital LLC. increased its position in Danaher by 4.4% during the 4th quarter. Defender Capital LLC. now owns 137,951 shares of the conglomerate’s stock worth $31,667,000 after purchasing an additional 5,866 shares during the period. Ibex Wealth Advisors purchased a new stake in Danaher during the 4th quarter worth about $2,715,000. Hantz Financial Services Inc. boosted its position in Danaher by 37.7% during the fourth quarter. Hantz Financial Services Inc. now owns 17,210 shares of the conglomerate’s stock worth $3,951,000 after acquiring an additional 4,710 shares during the last quarter. Montrusco Bolton Investments Inc. lifted its position in Danaher by 0.6% during the fourth quarter. Montrusco Bolton Investments Inc. now owns 1,715,826 shares of the conglomerate’s stock worth $382,936,000 after buying an additional 9,942 shares during the period. Finally, Foster Victor Wealth Advisors LLC grew its holdings in Danaher by 45.4% in the fourth quarter. Foster Victor Wealth Advisors LLC now owns 53,029 shares of the conglomerate’s stock valued at $12,640,000 after purchasing an additional 16,555 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Down 10.0 %

DHR opened at $223.12 on Thursday. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The stock has a market cap of $161.15 billion, a PE ratio of 42.58, a P/E/G ratio of 4.43 and a beta of 0.83. The business’s fifty day simple moving average is $236.09 and its 200 day simple moving average is $253.66. Danaher Co. has a 52 week low of $223.00 and a 52 week high of $281.70.

Danaher (NYSE:DHR) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. During the same quarter in the previous year, the firm earned $2.09 EPS. As a group, research analysts expect that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.48%. The ex-dividend date of this dividend is Friday, December 27th. Danaher’s payout ratio is 20.61%.

Analyst Ratings Changes

Several research firms have commented on DHR. Robert W. Baird cut their price objective on Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research report on Tuesday. Raymond James reduced their price target on shares of Danaher from $300.00 to $275.00 and set an “outperform” rating on the stock in a research report on Tuesday, January 21st. Royal Bank of Canada lowered their target price on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Bank of America raised Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target on the stock in a report on Friday, December 13th. Finally, Barclays dropped their price target on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $284.14.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.